Completed NA INTERVENTIONAL 2-arm NCT04072159

Community Pharmacists Vaccinate Against Cancer (CPVAC)

Community Pharmacists Vaccinating Against Cancer (CPVAC): A Pilot Randomized Controlled Trial Aimed at Increasing Human Papillomavirus Vaccine Completion Rates Among Racially/Ethnically Diverse Yout

Sponsor: Adelante Healthcare

Conditions Human Papillomavirus Vaccines

Interventions Community Pharmacists Vaccinating Against Cancer

Updated 7 times since 2019 Last updated: Jan 30, 2024 Started: Apr 1, 2019 Primary completion: Feb 1, 2021 Completion: Feb 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Human Papillomavirus Vaccines, this trial is completed. The trial is conducted by Adelante Healthcare and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2024 — Jul 2024 [monthly]

Completed NA
Dec 2021 — Mar 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Dec 2021 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Jul 2020 — Jan 2021 [monthly]

Recruiting NA
Sep 2019 — Jul 2020 [monthly]

Recruiting NA

First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Adelante Healthcare
Arizona State University
National Institute on Minority Health and Health Disparities (NIMHD)

Data source: Arizona State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mesa, United States